Portfolio

INBRAIN Neuroelectronics Announces Collaboration to Advance Graphene-Based Brain-Computer Interfaces

September 15, 2025

INBRAIN Neuroelectronics has signed a know-how collaboration agreement with Mayo Clinic to accelerate the development and commercialization of its graphene-based brain-computer interface therapeutics (BCI-Tx). Business Wire Key points: They will evaluate the BCI-Tx platform in IRB-approved settings for neurological disorders. Business Wire INBRAIN is opening a U.S. subsidiary, starting with a Boston office, while keeping global headquarters and R&D in Barcelona. 

 

Read more